HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Rui Liu Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

6/2022Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.
1/2021A novel HBsAg-based model for predicting significant liver fibrosis among Chinese patients with immune-tolerant phase chronic hepatitis B: a multicenter retrospective study.
7/2020Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.
11/2016Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
8/2016Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
5/2015Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.
12/2014A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity.
1/2013Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Rui Liu Research Topics

Disease

11Chronic Hepatitis B
01/2024 - 01/2013
8Liver Cirrhosis (Hepatic Cirrhosis)
06/2022 - 01/2013
7Fibrosis (Cirrhosis)
06/2022 - 01/2013
4Inflammation (Inflammations)
08/2023 - 01/2013
3Infections
06/2022 - 02/2016
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 10/2015
2Hepatitis
08/2016 - 02/2016
1Chronic Hepatitis (Chronic Active Hepatitis)
10/2015
1Persistent Infection
05/2015
1Liver Diseases (Liver Disease)
01/2013

Drug/Important Bio-Agent (IBA)

7Alanine Transaminase (SGPT)IBA
01/2024 - 12/2014
5Antiviral Agents (Antivirals)IBA
08/2023 - 10/2015
5Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2022 - 05/2015
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2022 - 11/2016
4Hepatitis B e AntigensIBA
01/2021 - 05/2015
4Ceruloplasmin (Ferroxidase)IBA
07/2020 - 01/2013
3Biomarkers (Surrogate Marker)IBA
11/2016 - 01/2013
2Alanine (L-Alanine)FDA Link
01/2023 - 12/2014
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2022 - 07/2020
1guanidinopropylsuccinic acid (GPSA)IBA
06/2022
1AlbuminsIBA
06/2022
1Indicators and Reagents (Reagents)IBA
07/2020
1GlobulinsIBA
11/2016
1DNA (Deoxyribonucleic Acid)IBA
10/2015
1Bile Acids and Salts (Bile Acids)IBA
12/2014
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2013

Therapy/Procedure

3Therapeutics
08/2023 - 07/2020